-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MEFvTbQ1/C0V4YHwjwNA/pJ603EIB6zuIySRlRADVGZU4b50bwDU6jQtotudt9Iy /CpMram3wg1MWxqothwlvQ== 0000000000-09-064200.txt : 20100106 0000000000-09-064200.hdr.sgml : 20100106 20091112161526 ACCESSION NUMBER: 0000000000-09-064200 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091112 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 PUBLIC REFERENCE ACCESSION NUMBER: 0000950123-09-003692 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C4Q(#`@;V)J#3P\+TQI;F5A7!E+UA2968^/G-T M-IB8F)D8&)@8!PJ&"#``"_S`(<-"F5N9'-T%LP(#`@-C$R(#'1=+T5X=$=3=&%T93P\+T=3 M,"`V,R`P(%(^/CX^+U1Y<&4O4&%G93X^#65N9&]B:@TU-"`P(&]B:@T\/"]3 M=6)T>7!E+U1R=654>7!E+T9O;G1$97-C7!E+U1R=654 M>7!E+T9O;G1$97-C6#4[\K[6\UC`#--M!4W`983[$TL+B6/6 ML:6$4CJ#.`5W]_$9MF0Z-G_*!%9)6LN-+`0D909_D#6!ZT06QD/\O4.VDE"- M3P?D68?<0JR;Z@%F(4<]36C!+PL4]BMU'6PHB>F#49.O-ORFG[]?C;VYJ9[$ MQIG;WX1"!TR`4[H`YY_XXPG=^5#83AS=M\NJD"5\J+(L4=D$;N])1,S*+$;J M96&/=2]%#LL?(GULY).`SWDN4R1F=B(]P`M[/.[U^GU>7R&C1&VW2X5KE5F33@#%&L/SMN<:Z_-.Z M6A9\(-0ZR.V@ME.'<*M*;=`F[B?(*P7-O8"5K+'Y\$4D"I9E)C*(1"HVVOP> M:\T_'^E$<&@'WEMLA2&3P4I\4X]8=:)>@(?=&(V73`GG/RTY'"GY."3<#FHH M.5JNT`@7D+>L+AX4!A9?[,;ZM.<='TZ"V4_YS`W6ZG;MJ:W3]J8B@.189&FU>2A$@SVI'A4H\21Q_*L<7O2_K5&.+=TZ MC"U(Z.VF3-L9DUH[VG%#^U-[M2G,'PV+#9?E]UH_PZ'K#AUPC_5R.^!>_J]V M64'^J'!&E.:JSQ%E@W`-SHVLH9'M(\=E-C$')C=DE7>VP7UF83O.K?4-LGO] M]8S;UK+$VT(4+Q,S0'#`\#RY\.SW$SX_O^3PVCOIQ#Z-CR+/E7B!6P)W4F0% M-L/XO>GPYIL/D//>@!=U+>LFT7=<`Y%4(FTJ_*QT!\T-]-AI`]V1MBQCZW\! M!@"8=6"<#0IE;F1S=')E86T-96YD;V)J#34X(#`@;V)J#3P\+U-U8G1Y<&4O M5')U951Y<&4O1F]N=$1EJ'-,-(9>I,N,(#T+B`=!%$89@88R@###$ULB*A`1!$1`460H(`!HZ%( MK(AB(2BH8`]($%!B,(JHJ&1&UDI\>7GOY>7WQ[W?VF?O<_?9>Y^U+@`D3Q\N M+P66`B"9)^`'>CC35X5'T+']``9X@`&F`#!9Z:F^0>[!0"0O-Q=ZNL@)_(O> M#`%(_+YEZ.E/IX/_3]*L5+X``,A?Q.9L3CI+Q/DB3LH4I(KM,R*FQB2*&4:) MF2]*4,1R8HY;Y*6??1;94!&;B)C$#PYT$?%R`'"DN"\XY@L6 M<+($XD.YI*1F\[EQ\0*Z+DN/;FIMS:![[M(KT*^-PSB-;WA^VO_%+J M`&#,BFJSZP];S'X`.K8"('?_#YOF(0`D17UKO_'%>6CB>8D7"%)MC(TS,S.- MN!R6D;B@O^M_.OP-??$](_%VOY>'[LJ)90J3!'1QW5@I22E"/CT]E?^IB?\P[$]:G&N1 M*/6?`#7*"$C=H`+DYSZ`HA`!$GE0W/7?^^:##P7BFQ>F.K$X]Y\%_?NN<(GX MD,X`9P\QBL5AYK`'6#NN'96(%V`+L?NPQ M[#GL('8<^Q9'Q*GBS'#NN`@<#Y>'*\$AX1202U8G6Q``BE[B)6$$\ M3KQ"'"6^(\F0]$DNI$B2D+23=(1TGG2/](I,)FN3'DDN58R1[)<\J3D#LHERC@50]6A>E$3J$74;ZC]U!E9&=EELJ&R6;)5LF=D1V@(39OF M14NBE=!.T(9H[YGR;O*) M\KOE.^0?*:`4]!4"%#(5#BI<4IA6I"K:*K(4"Q5/*-Y7@I7TE0*5UBD=5NI3 MFE564?903E7>KWQ1>5J%IN*HDJ!2IG)694J5HFJORE4M4SVG^HPN2W>B)]$K MZ#WT&34E-4\UH5JM6K_:O+J.>HAZGGJK^B,-@@9#(U:C3*-;8T935=-7,U>S M6?.^%EZ+H16OM4^K5VM.6T<[3'N;=H?VI(ZYM M/8P>0R]1[X#>37U8WT(_7K]*_X8!;&!IP#4X8#"P%+W4>BEO:=W284.2H9-A MAF&SX:@1SJ/U:>MW-I8V`IL3-K_8&MHFVC;93B[76/MC]D/^*@YL!TJ'-XXJCAR'9L<)QPTG-*<#KF],+9 MQ)GOW.8\YV+CLM[EO"OBZN%:Z-KO)N,6XE;I]MA=W3W.O=E]QL/"8YW'>4^T MI[?G;L]A+V4OEE>CU\P*JQ7K5_1XD[R#O"N]G_CH^_!]NGQAWQ6^>WP?KM1: MR5O9X0?\O/SV^#WRU_%/\_\^`!/@'U`5\#30-#`WL#>($A05U!3T)M@YN"3X M08ANB#"D.U0R-#*T,70NS#6L-&QDE?&J]:NNARN$<\,[([`1H1$-$;.KW5;O M73T>:1%9$#FT1F=-UIJK:Q76)JT]$R49Q8PZ&8V.#HMNBO[`]&/6,6=CO&*J M8V98+JQ]K.=L1W89>XICQRGE3,3:Q9;&3L;9Q>V)FXIWB"^/G^:Z<"NY+Q,\ M$VH2YA+]$H\D+B2%);4FXY*CDT_Q9'B)O)X4E92LE(%4@]2"U)$TF[2]:3-\ M;WY#.I2^)KU30!7]3/4)=85;A:,9]AE5&6\S0S-/9DEG\;+ZLO6S=V1/Y+CG M?+T.M8ZUKCM7+7=S[NAZI_6U&Z`-,1NZ-VILS-\XOLECT]'-A,V)FW_(,\DK MS7N])6Q+5[YR_J;\L:T>6YL+)`KX!WSWM M9?2RPK+7>Z/V7BU?5EZSC[!/N&^DPJ>B<[_F_EW[/U3&5]ZI5'\8-#0H- M10T?C_".C!P-/-K3:-78V*345-(,-PN;IXY%'KOYC>LWG2V&+;6MM-:BX^"X M\/BS;Z._'3KA?:+[).-DRW=:WU6W4=H*VZ'V[/:9COB.D<[PSH%3*TYU=]EV MM7UO]/V1TVJGJ\[(GBDY2SB;?W;A7,ZYV?.IYZ\+UVY['[Y8J]3[[DK=E=.7[6Y>NH:XUK'=N;70/+!\X..@Q>N.5ZZ_)MK]O7[ZR\,S`4,G1W.')XY"[[[N2]I'LO M[V?$CJ4?ECY4>U_VH]V/KB.7(F5'7T;XG04\>C+'&GO^4_M.' M\?RGY*?E$ZH3C9-FDZ>GW*=N/EO];/QYZO/YZ8*?I7^N?J'[XKM?''_IFUDU M,_Z2_W+AU^)7\J^.O%[VNGO6?_;QF^0W\W.%;^7?'GW'>-?[/NS]Q'SF!^R' MBH]Z'[L^>7]ZN)"\L/";``,`]X3S^PH-"F5N9'-T%LM-38X("TS,#<@,C`P,"`Q,#`W72]!7!E+T9O;G1$97-C2A4:6UE7!E+T]B:E-T;3X^)0@%QTEHR)'8H1>A%XJ]<4T=R2AR2=Z^_VKJ M.*<6[45)*=@>[>J?;W9F5BM[RB@GF654D+8%KDA[3$AR*B.IR&>2I*9<:9*& M"N-(6J@\;N)2%H:DAT#"!Q]C(`/%N9RBOU>2\)'>65(*DJR@2,JM)@77O/"D MP"L,=.`5.728RA1T$>&APZ5$$)W!.D4:4MP@K6`MQI`H<+0!VDJD`71F23M8 M&_.!+3`&SQJ,P;.(@TOE`(VA/?(VX'FL&RFH'"D;\'+GR8!7(`FDK@KGR,2E MH$`FA[48HW(258JAI+6TM24.4-.,SL1IV82J'3,=>Z,9*/8:#:& MC67CV'@V.1NF:*9HIFBF:*9HIFBF:*9HIFBF:*88IABF&*88IABF&*88IABF M&*88IMB.\E6<4G=7C,0H3%IQ6%:S=[O''\Y';]YW)3A>7=]<9''C17DWM5\M MYE48?2M1Q+WY;-4$L=/4RV&Y7`]/5FV4B-&RK,3G\='A6Y6=-N&J;J[+M@U3 M<2I&J\N;23-?MBP:K9:A>3@Q/AG@.\1WK[/HUOQ[J%?KVVCM=GTK=N8_Q''$ M+L#AP[S*"&$9T&7\0LIQ.RHG@9QV(POV7$[+B/<>^XCMZKMAJC`@U$'VXS_6F3M_M70\?8K M%5SE^>O%MNKU:HX72`S^WQ^=J.Y@?0H,UX?0`64X4O-?1^KZ9)J1U?Q3Q"DME2D]5?U[.GSQ?PH0#SO]XE^9WP97J9YZ[=EG#]BGW51] M]H![YF5[QX+8I8A]BCCOO7B(^^P!_S13G?*`ZS\_X#\%&`#\X8[R#0IE;F1S M=')E86T-96YD;V)J#3(@,"!O8FH-/#PO3G5M7!E+UA-3"],96YG=&@@-#`Q-R]4>7!E+TUE=&%D871A/CYS=')E86T- M"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZDY4 M8WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B M('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#0N,"UC,S$V(#0T+C(U,SDR,2P@ M4W5N($]C="`P,2`R,#`V(#$W.C$T.C,Y(CX*("`@/')D9CI21$8@>&UL;G,Z M&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q M+C,O(CX*("`@("`@("`@/'!D9CI03Y314,\+W!D M9G@Z0V]M<&%N>3X*("`@("`@("`@/'!D9G@Z4V]U#I3;W5R8V5-;V1I9FEE9#X*("`@("`@/"]R M9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&%P.D-R96%T941A M=&4^,C`P.2TQ,2TQ,E0Q-CHP.#HT-"TP-3HP,#PO>&%P.D-R96%T941A=&4^ M"B`@("`@("`@(#QX87`Z365T861A=&%$871E/C(P,#DM,3$M,3)4,38Z,#@Z M-#&%P34TZ26YS=&%N8V5)1#YU=6ED.F$P M,C&%P34TZ26YS M=&%N8V5)1#X*("`@("`@("`@/'AA<$U-.G-U8FIE8W0^"B`@("`@("`@("`@ M(#QR9&8Z4V5Q/@H@("`@("`@("`@("`@("`\"UD969A=6QT(CY6:6$@1F%C4PI+T-R96%T;W(H06-R;V)A="!01$9-86ME')E9@T*,"`U,0T*,#`P,#`P M,#`P,"`V-34S-2!F#0HP,#`P,#`W,C$R(#`P,#`P(&X-"C`P,#`P,#@Q,3,@ M,#`P,#`@;@T*,#`P,#`P.#$T-R`P,#`P,"!N#0HP,#`P,#`X,3 -----END PRIVACY-ENHANCED MESSAGE-----